Is Ozempic a threat to Ireland's €18bn dairy industry?

With dietary drugs on the rise and the food industry already seeing their effects, Irish dairy is assessing the impact they might have
Twenty five to 30 million US adults are taking weight-loss drugs, about 10-12% of the total population. Picture illustration: Mario Tama/Getty Images

Twenty five to 30 million US adults are taking weight-loss drugs, about 10-12% of the total population. Picture illustration: Mario Tama/Getty Images

The topic of the consumer is never too far behind trade talks for the dairy market.

The rise in weight-loss drugs like Ozempic means food producers worldwide are assessing their future with more buyers consuming less and placing more focus on wellness and health.

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

Farming

Newsletter

Stay ahead of the season. Sign up for insights, expert advice and stories shaping Irish agriculture.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited